Get the Stockscreener App
3.45
2.87%
-0.102
After Hours:
3.35
-0.10
-2.90%
Cumberland Pharmaceuticals Inc stock is traded at $3.45, with a volume of 26,071.
It is down -2.87% in the last 24 hours and up +1.62% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
See More
Previous Close:
$3.552
Open:
$3.53
24h Volume:
26,071
Relative Volume:
0.50
Market Cap:
$51.61M
Revenue:
$37.79M
Net Income/Loss:
$-10.38M
P/E Ratio:
-4.726
EPS:
-0.73
Net Cash Flow:
$-1.00M
1W Performance:
+10.22%
1M Performance:
+1.62%
6M Performance:
-14.39%
1Y Performance:
+169.53%
1-Day Range:
$3.3001
$3.6884
1-Week Range:
$3.08
$3.6884
52-Week Range:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
2525 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.45 | 53.14M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
Can volume confirm reversal in Cumberland Pharmaceuticals Inc.July 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Why Cumberland Pharmaceuticals Inc. stock is recommended by analystsTrend Reversal & Safe Capital Allocation Plans - newser.com
What the charts say about Cumberland Pharmaceuticals Inc. todayProduct Launch & Accurate Technical Buy Alerts - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Cumberland Pharmaceuticals (NASDAQ:CPIX) - MarketBeat
How to manage a losing position in Cumberland Pharmaceuticals Inc.Trade Volume Report & Low Risk Profit Maximizing Plans - newser.com
Is Cumberland Pharmaceuticals Inc. still worth holding after the dip2025 Volatility Report & Intraday High Probability Alerts - newser.com
Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S No Reason For Excitement - simplywall.st
Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsight - GlobeNewswire Inc.
Published on: 2025-10-06 05:25:30 - newser.com
Will Cumberland Pharmaceuticals Inc. benefit from macro trendsTrend Reversal & Accurate Entry/Exit Alerts - newser.com
Published on: 2025-10-06 02:33:45 - newser.com
Should you wait for a breakout in Cumberland Pharmaceuticals Inc.Earnings Trend Report & Precise Swing Trade Entry Alerts - newser.com
Sentiment analysis tools applied to Cumberland Pharmaceuticals Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Tick level data insight on Cumberland Pharmaceuticals Inc. volatilityWatch List & High Accuracy Swing Entry Alerts - newser.com
How to build a dashboard for Cumberland Pharmaceuticals Inc. stock2025 Year in Review & Weekly Top Gainers Alerts - newser.com
Cumberland Pharmaceuticals Announces Product Approval in Mexico - MarketScreener
Cumberland’s injectable ibuprofen receives approval in Mexico By Investing.com - Investing.com South Africa
Cumberland’s injectable ibuprofen receives approval in Mexico - Investing.com India
CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO - PR Newswire
Non-Opioid Pain Management Breakthrough: Cumberland's Injectable Ibuprofen Approved in Mexican Market - Stock Titan
Revolutionary Drug-Resistant Bacteria Fighter: Tabuk Brings Vibativ Antibiotic to Saudi Healthcare System - Stock Titan
Is Cumberland Pharmaceuticals Inc a good long term investmentEarnings Per Share Trends & Free Long-Term Investment Planning - earlytimes.in
What analysts say about Cumberland Pharmaceuticals Inc stockTechnical Analysis Insights & Reinvest for Maximum Compounding Returns - earlytimes.in
New Horizons in Intravenous IV Ibuprofen Market: Future - openPR.com
Published on: 2025-09-27 19:30:55 - newser.com
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):